L Reneman
Overview
Explore the profile of L Reneman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
550
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Poirot M, Caan M, Ruhe H, Bjornerud A, Groote I, Reneman L, et al.
Sci Rep
. 2022 Oct;
12(1):16712.
PMID: 36202934
Radiomics in neuroimaging uses fully automatic segmentation to delineate the anatomical areas for which radiomic features are computed. However, differences among these segmentation methods affect radiomic features to an unknown...
2.
de Vries R, Jaeger B, Hellebrekers D, Reneman L, Verhamme C, Smeets H, et al.
Clin Neurol Neurosurg
. 2021 May;
206:106637.
PMID: 34022688
Variants of the C19ORF12-gene have been described in patients with spastic paraplegia type 43 and in patients with mitochondrial membrane protein-associated neurodegeneration (MPAN), a subtype of neurodegeneration associated with brain...
3.
Walhovd K, Amlien I, Schrantee A, Rohani D, Groote I, Bjornerud A, et al.
AJNR Am J Neuroradiol
. 2020 May;
41(5):758-765.
PMID: 32414901
Background And Purpose: Although methylphenidate is frequently used to treat children with attention-deficit/hyperactivity disorder, it is currently unknown how methylphenidate affects brain development. In a randomized controlled trial, we investigated...
4.
Kaag A, Schulte M, Jansen J, van Wingen G, Homberg J, van den Brink W, et al.
Drug Alcohol Depend
. 2018 Apr;
187:186-194.
PMID: 29679913
Background: Neuroimaging studies have demonstrated gray matter (GM) volume abnormalities in substance users. While the majority of substance users are polysubstance users, very little is known about the relation between...
5.
Mugie S, Koppen I, van den Berg M, Groot P, Reneman L, de Ruiter M, et al.
Neurogastroenterol Motil
. 2017 Oct;
30(3).
PMID: 28975729
Background: Decreased sensation of urge to defecate is often reported by children with functional constipation (FC) and functional nonretentive fecal incontinence (FNRFI). The aim of this cross-sectional study was to...
6.
Schrantee A, Bouziane C, Bron E, Klein S, Bottelier M, Kooij J, et al.
Brain Imaging Behav
. 2017 Mar;
12(2):402-410.
PMID: 28321605
Stimulant prescription rates for attention deficit hyperactivity disorder (ADHD) are increasing, even though potential long-term effects on the developing brain have not been well-studied. A previous randomized clinical trial showed...
7.
Schrantee A, Mutsaerts H, Bouziane C, Tamminga H, Bottelier M, Reneman L
Neuroimage Clin
. 2016 Dec;
13:123-129.
PMID: 27942455
Methylphenidate (MPH) is a stimulant drug and an effective treatment for attention-deficit/hyperactivity disorder (ADHD) in both children and adults. Pre-clinical studies suggest that the response to stimulants is dependent on...
8.
Tamminga H, Reneman L, Huizenga H, Geurts H
Psychol Med
. 2016 Mar;
46(9):1791-807.
PMID: 27019103
Attention-deficit/hyperactivity disorder (ADHD) in childhood and adulthood is often treated with the psychostimulant methylphenidate (MPH). However, it is unknown whether cognitive effects of MPH depend on age in individuals with...
9.
van der Marel K, Bouet V, Meerhoff G, Freret T, Boulouard M, Dauphin F, et al.
Neuroscience
. 2015 May;
309:243-58.
PMID: 25934041
Methylphenidate (MPH) is a widely prescribed stimulant drug for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents. Its use in this age group raises concerns regarding...
10.
Bottelier M, Schouw M, de Ruiter M, Ruhe H, Lindauer R, Reneman L
Brain Imaging Behav
. 2015 Jan;
9(4):878-86.
PMID: 25563230
D-amphetamine (dAMPH) and methylphenidate (MPH) are stimulants used in the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Preclinical studies have shown that in healthy animals, dAMPH induces dopamine (DA) dysfunction,...